Pab Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -8875.62%
(FY 2022)
- Ebitda -8785.52%
(FY 2022)
- Net Worth -769.37%
(FY 2022)
- Total Assets 4883.63%
(FY 2022)
About Pab Remedies
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amarjit Singh, Basant Gupta, and Pawan Kumar serve as directors at the Company.
- CIN/LLPIN
U24110PB2020PTC052282
- Company No.
052282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pab Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Kumar  | Director | 11-Nov-2020 | Current |
| Amarjit Singh | Director | 11-Nov-2020 | Current |
| Basant Gupta | Director | 11-Nov-2020 | Current |
Financial Performance of Pab Remedies.
Pab Remedies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 8875.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 769.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pab Remedies?
In 2021, Pab Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pab Consultants Private LimitedActive 3 years 11 monthsAmarjit Singh, Basant Gupta and 1 more are mutual person
Gastronomic Foodbook Ventures LlpActive 6 years 8 monthsAmarjit Singh and Pawan Kumar are mutual person
- Pabaamtech Softsolution Private LimitedActive 5 years 5 months
Amarjit Singh and Basant Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pab Remedies?
Pab Remedies has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pab Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pab Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
